期刊文献+

(+)-9-氨基-4-去甲氧基-9-去氧柔红霉素酮的合成 被引量:2

Synthesis of (+)-9-Amino-4-demethoxy-9-deoxydaunomycinone
下载PDF
导出
摘要 1,4-萘醌经氢化还原、甲基化、还原、环氧化、还原和氧化反应制得5,8-二甲氧基-2-萘满酮(8),经Strecker反应、甲酯化、拆分、酯缩合、还原、乙酰化反应得到(R)-(-)-2-乙酰基-2-乙酰胺基-5,8-二甲氧基-1,2,3,4-四氢萘(13)。13与邻苯二甲酸酐经傅-克酰化、缩酮化、光化反应和水解反应得到抗肿瘤药氨柔比星中间体(+)-9-氨基-4-去甲氧基-9-去氧柔红霉素酮。 (+)-9-Amino-4-demethoxy-9-deoxydaunomycinone, a key intermediate of antitumor agent amrubicin, was synthesized from 1,4-naphthoquinone by reduction, methylation, reduction, epoxy reaction, reduction and oxidation to give 5,8-dimethoxy-2-tetralone, which was subjected to Strecker's reaction, esterification, resolution, ester condensation, reduction and acylation to afford (R) - (-) -2-acetyl-2-acetamido-5,8-dimethoxy-1,2,3,4- tetrahydronaphthalene, followed by Friedel-Crafts reaction with phthalic anhydride, protection with ethylene glycol, photochemical reaction and then hydrolysis.
出处 《中国医药工业杂志》 CAS CSCD 北大核心 2009年第11期805-809,共5页 Chinese Journal of Pharmaceuticals
关键词 (+)-9-氨基-4-去甲氧基-9-去氧柔红霉素酮 氨柔比星 抗肿瘤药 中间体 合成 (+)-9-amino-4-demethoxy-9-deoxydaunomycinone amrubicin antitumor agent intermediate synthesis
  • 相关文献

参考文献16

  • 1Yana T, Negoro S, Takada M, et al. Phase Ⅱ study of amrubicin (SM-5887), a 9-amino-anthracycline, in previously untreated patients with extensive stage small-cell lung cancer (ES-SCLC) : a West Japan Lung Cancer Group trial[J]. ProcAm Soc Clin Oncol, 1998, 17(1): 450a.
  • 2Kurata T, Okamoto I, Tamura K, et al. Amrubicin for non-small-cell lung cancer and small-cell lung cancer [J]. Invest New Drugs, 2007, 25 (5) : 499-504.
  • 3Dykstra HB. Acetylene polymers and their derivations. ⅩⅩⅢ. The preparation and polymerization of oxyprenes [J]. J Am Chem Soc, 1935, 57 (11) : 2255-2259.
  • 4Lewis TR, Dickinson WB, Archer S. 1,4-Dimethoxy-5- methyl-6-tetralone and 1,4-dimethoxy-5,5-dimethyl-6- tetralone [J]. J Am Chem Soc, 1952, 74 (21) : 5321-5324.
  • 5Gray AD, Smyth TP. Clean-chemistry synthesis of 2-tetralones in a single-stage acylation-cycloalkylation process [J]. J Org Chem, 2001, 66 (21 ) : 7113-7117.
  • 6Fuson RC, Rabjone N. Mesitylacetic acid [J]. Org Synth, 1923, 3: 557-558.
  • 7Burckhalter JH, Campbell JR. Ethylene and phenylacetyl chloride in the Friedel-Crafts reaction. Novel syntheses of 2- tetralones and benzofuranones [J]. J Org Chem, 1961, 26(11): 4232-4235.
  • 8Manitto P, Speranza G, Monti D, et al. Baker's yeast mediated reduction of aromatic ring substituted 2-tetralones [J]. Tetrahedron, 1995, 51 (42): 11531-11546.
  • 9Tririya G, Zanger M. Synthesis of anthracyclinone precursor: 5,12-dihydroxy- 1,3,4-trihydronaphthacene-2,6,11 -quinone [J]. Synth Commun, 2004, 34 (17) : 3047-3059.
  • 10Nixon JA, Pioch RP, Schaus JM, et al. Ring-substituted 2-amino-1,2,3,4,-tetrahydronaphthalenes: US, 5026707 [P]. 1991-06-25. (CA 1989, 112: 235346).

同被引文献22

  • 1袁永荣,常萍.肺癌用药盐酸氨柔比星[J].齐鲁药事,2004,23(5):61-61. 被引量:6
  • 2Ogawa M. Novel anticancer drugs in Japan [J]. J Cancer Res Clin Oncol, 1999, 125 (3-4): 134-140.
  • 3Kurata T, Okamoto I, Tamura K, et al. Amrubicin for non-small-cell lung cancer and small-cell lung cancer [J]. Invest NewDrugs, 2007, 25(5): 499-504.
  • 4Yokota S, Negoro S, Yana T, et al. Phase II study of amrubicin (SM-5887), a 9-amino-anthracycline, in previously untreated paitents with extensive stage small-cell cancer(ES-SCLC) : A West Japan Lung Cancer Group Trial [J]. ProcAm Soc Clin Oncol, 1998, 17 (1) : 450.
  • 5Tririya G, Zanger M. Synthesis of anthracyclinone precursor: 5,12-dihydroxy- 1,3,4-trihydronaphthacene-2,6,11 -quinone [J]. Synth Commun, 2004, 34 (17): 3047-3059.
  • 6Alexander J, Mitscher LA. A short, efficient synthesis of an anthracycline antitumor antibiotic synthon [J]. Tetrahedron Lett, 1978, 19(37):3403-3406.
  • 7Lewis TR, Dickinson WB, Archer S. 1,4-Dimethoxy-5- methyl-6-tetralone and 1,4-dimethoxy-5,5-dimethyl-6- tetralone [J]. JAm Chern Soc, 1952, 74 (21) : 5321-5324.
  • 8Kende AS. 5,12-Epoxy-naphthacene-6,11-dione derivatives: US, 4116981 [P] 1978-09-26. (CA 1978, 90: 87251).
  • 9Nixon JA, Pioch RP, Schaus JM, et al. Ring-substituted 2-amino-l,2,3,4-tetarhydronaphthalenes: US, 5026707 [P]. 1989-11-26. (CA 1989, 112: 235346).
  • 10Arvidsson LE, Hacksell U, Johansson A, et al. 8-Hydroxy- 2-(alkylamino) tetralins and related compounds as central 5-hydroxytryptamine receptor agonists [J]. J Med Chem, 1984, 27(1): 45-51.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部